Recursion Pharmaceuticals $121 million Series C for AI drug discovery

Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors.

The funds will be invested to continue building Recursion's AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology.

Cala Health raises $50m for wearable tremor therapy
Cala Health, which develops bioelectrical therapies for chronic diseases, has closed a $50 million Series C financing round
Alex Guest Tue, 21/05/2019 - 11:36

MedCrypt raises $5.3 million as concerns for medtech cybersecurity grow

MedCrypt, a medical device cybersecurity software provider, has closed a Series A round of $5.3 million, led by Section 32, with participation from Eniac Ventures and Y Combinator. The funds will be used for sales and marketing, and for product development.

Sonde Health raises $16 million Series A for vocal diagnostics

Sonde Health, which is developing a voice-based diagnostics platform, has secured $16 million in a Series A financing round led by M Ventures, with MP Healthcare Venture Management, Neoteny 4, LP, Canepa Healthcare, and founder PureTech Health

Signum Surgical wins €3.6 million grants for colorectal disease therapy

Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million:  €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.